mds (myelodysplastic syndrome)
Showing 1 - 7 of 7
Severe Aplastic Anemia, MDS (Myelodysplastic Syndrome) Trial in Baltimore, Bethesda, Minneapolis (Miltenyi CD34 Reagent System,
Recruiting
- Severe Aplastic Anemia
- MDS (Myelodysplastic Syndrome)
- Miltenyi CD34 Reagent System
- Donor derived G-CSF mobilized PBC
-
Baltimore, Maryland
- +2 more
Jan 25, 2023
AML - Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome), Mixed Phenotype Acute Leukemia Trial in Palo Alto (T-allo10)
Recruiting
- AML - Acute Myeloid Leukemia
- +5 more
- T-allo10
-
Palo Alto, CaliforniaLucile Packard Children's Hospital
Feb 2, 2022
Personalized Medicine Program on Myelodysplastic Syndromes:
Unknown status
- MDS (Myelodysplastic Syndrome)
-
Rozzano, Milano, ItalyIRCCS Humanitas Research Hospital
Feb 23, 2021
MDS (Myelodysplastic Syndrome), Myeloproliferative Disorder, Lymphoma, Non-Hodgkin Trial run by the NHLBI (Graft Manipulation
Completed
- MDS (Myelodysplastic Syndrome)
- +4 more
- Graft Manipulation (CD34+ Selection)
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 20, 2020
Chronic Lymphocytic Leukemia, CML (Chronic Myelogenous Leukemia), MDS (Myelodysplastic Syndrome) Trial run by the NHLBI (MVST,
Terminated
- Chronic Lymphocytic Leukemia
- +4 more
- MVST
- MVSTr
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019
CML (Chronic Myelogenous Leukemia), CLL (Chronic Lymphocytic Leukemia), AML (Acute Myelogenous Leukemia) Trial run by the NHLBI
Completed
- CML (Chronic Myelogenous Leukemia)
- +4 more
- Miltenyi system
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 14, 2018